JEST
GSK icon

JTC Employer Solutions Trustee’s GSK GSK Stock Holding History

JTC Employer Solutions Trustee’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$499M Sell
9,042,389
-5,385,620
-37% -$292M 41.69% 1
2025
Q4 		$708M Sell
14,428,009
-169,176
-1% -$7.89M 48.05% 1
2025
Q3 		$630M Sell
14,597,185
-400,199
-3% -$15.6M 54.03% 1
2025
Q2 		$576M Sell
14,997,384
-262,984
-2% -$10M 54.9% 1
2025
Q1 		$592M Sell
15,260,368
-5,018,196
-25% -$184M 48.6% 1
2024
Q4 		$682M Sell
20,278,564
-202,398
-1% -$7.29M 48.38% 1
2024
Q3 		$837M Sell
20,480,962
-399,462
-2% -$16.3M 54.67% 1
2024
Q2 		$804M Sell
20,880,424
-260,588
-1% -$11M 53.74% 1
2024
Q1 		$909M Buy
21,141,012
+8,800,822
+71% +$363M 57.69% 1
2023
Q4 		$458M Sell
12,340,190
-104,270
-0.8% -$3.74M 41.35% 1
2023
Q3 		$451M Sell
12,444,460
-1,286,460
-9% -$45.7M 41.96% 1
2023
Q2 		$489M Sell
13,730,920
-262,288
-2% -$9.41M 46.61% 1
2023
Q1 		$498M Sell
13,993,208
-3,978,762
-22% -$139M 52.83% 1
2022
Q4 		$631M Buy
17,971,970
+13,264,687
+282% +$442M 54.05% 1
2022
Q3 		$139M Sell
4,707,283
-2,253,289
-32% -$85.4M 23.02% 1
2022
Q2 		$379M Sell
6,960,572
-253,004
-4% -$14M 49.49% 1
2022
Q1 		$393M Buy
7,213,576
+2,418,907
+50% +$131M 43.49% 1
2021
Q4 		$264M Sell
4,794,669
-264,786
-5% -$13.8M 32.64% 1
2021
Q3 		$242M Sell
5,059,455
-873,139
-15% -$43.9M 32.36% 1
2021
Q2 		$295M Buy
+5,932,594
New +$285M 43.57% 1

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JTC Employer Solutions Trustee's GSK Position: Q1 2026 in Review

JTC Employer Solutions Trustee reduced its GSK (GSK) stake by 37% in Q1 2026, selling an estimated $292M and leaving 9,042,389 shares worth $499M. The position accounts for 41.69% of the portfolio, ranked #1.

JTC Employer Solutions Trustee first reported a position in GSK in Q2 2021 and has held it in 20 quarters since. The position peaked at $909M in Q1 2024. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

  • JTC Employer Solutions Trustee held 9,042,389 shares of GSK worth $499M as of Q1 2026.
  • JTC Employer Solutions Trustee sold 5,385,620 GSK shares in Q1 2026, an estimated $292M.
  • GSK made up 41.69% of JTC Employer Solutions Trustee's portfolio in Q1 2026, its #1 holding.
  • JTC Employer Solutions Trustee first reported a position in GSK in Q2 2021 and has held it in 20 quarters since.
  • JTC Employer Solutions Trustee's GSK position peaked at $909M in Q1 2024.
  • 1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on JTC Employer Solutions Trustee's 13F filing for Q1 2026, filed 19 May 2026.